Should investigators be involved in more than one similar type trial?

Institut for Folkesundhedsvidenskab

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Should investigators be involved in more than one similar type trial? / Torp-Pedersen, C; Køber, L.

I: Cardiovascular Drugs and Therapy, Bind 15, Nr. 2, 2001, s. 181-5.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Torp-Pedersen, C & Køber, L 2001, 'Should investigators be involved in more than one similar type trial?', Cardiovascular Drugs and Therapy, bind 15, nr. 2, s. 181-5.

APA

Torp-Pedersen, C., & Køber, L. (2001). Should investigators be involved in more than one similar type trial? Cardiovascular Drugs and Therapy, 15(2), 181-5.

Vancouver

Torp-Pedersen C, Køber L. Should investigators be involved in more than one similar type trial? Cardiovascular Drugs and Therapy. 2001;15(2):181-5.

Author

Torp-Pedersen, C ; Køber, L. / Should investigators be involved in more than one similar type trial?. I: Cardiovascular Drugs and Therapy. 2001 ; Bind 15, Nr. 2. s. 181-5.

Bibtex

@article{d136c750119d11df803f000ea68e967b,

title = "Should investigators be involved in more than one similar type trial?",

abstract = "Udgivelsesdato: 2001-Mar",

author = "C Torp-Pedersen and L K{\o}ber",

note = "Keywords: Adrenergic beta-Antagonists; Controlled Clinical Trials as Topic; Heart Failure; Humans; Myocardial Infarction; Patient Selection; Research Personnel",

year = "2001",

language = "English",

volume = "15",

pages = "181--5",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "2",